vimarsana.com

Latest Breaking News On - Sentara vascular specialists - Page 1 : vimarsana.com

Inari Medical (NARI) Reports Interim Two-Year Results from the ClotTriever CLOUT Registry

Inari Medical (NARI) Reports Interim Two-Year Results from the ClotTriever CLOUT Registry
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid dexterThomas tuAmerican venous forumInari medical incInari medicalSentara vascular specialistsChief medicalYear moderate severe

Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry

IRVINE, Calif., March 12, 2024 (GLOBE NEWSWIRE) Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing p.

United statesDavid dexterJohn hsuThomas tuInari medical incAmerican venous forumSentara vascular specialistsChief medicalYear moderate severeInari medical

Late-Breaking Clinical Trial outcomes from The VEINS Conference: CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment

Four late-breaking clinical trial outcomes from The VEINS Conference presented results from the CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment were present during the The VEINS Conference, taking place Oct. 28-30 in Las Vegas, NV.

United statesGeorgia generalMahmood razaviJay mathewsLas vegasDavidj dexterBradenton cardiology centerMercator medsystems incVenous endovascularYear clinical outcomesDeep vein thrombosis patients treatedMechanical thrombectomySentara vascular specialistsClottriever outcomesInari medicalVenous clinical severity score

Gore enrolls first patient in Gore ViaFort vascular stent iliofemoral study

Gore this week announced it enrolled the first U.S. patient in its pivotal study for its ViaFort vascular stent.

United statesGore viafortDavid dexterSentara vascular specialists

Inari Medical Announces Three New Data Sets to be Presented During Late-Breaking Clinical Trial Sessions at the 2022 TCT and VEINS Conferences

01.09.2022 - IRVINE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) - Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced .

United statesSteven abramowitz medstar heathDavid dexter sentaraLas vegasThomas tuInari medical incDavid dexterSentara vascular specialistsSteven abramowitzMedstar heathLate breaking clinical trialsChief medicalInari medical

vimarsana © 2020. All Rights Reserved.